The experts speak - Studying the potential of tenofovir to prevent sexual transmission of HIV: First steps

AIDS Patient Care and STDs

Volumn 19, Issue 1, 2005, Pages 1-4

  Thompson, Melanie ^a,b,c,d   Glaser, Vicki ^b  

^a AIDS Research Consortium of Atlanta   (United States)

^b Intl AIDS Soc USA's A ^*

^c AIDS Research Consortium of Atlanta   (United States)

^d Natl Institutes Hlth Off AIDS R   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TENOFOVIR;

CLINICAL RESEARCH; COUNSELING; DRUG EFFICACY; DRUG RESISTANCE; DRUG SAFETY; DRUG TOLERABILITY; HEALTH CARE ORGANIZATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL COOPERATION; NOTE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SIDE EFFECT; TREATMENT OUTCOME;

ADENINE; COMMUNICABLE DISEASE CONTROL; FEMALE; HIV INFECTIONS; HUMANS; MALE; PHOSPHONIC ACIDS; PRIMARY PREVENTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES; TREATMENT OUTCOME;

EID: 12844278590     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.1     Document Type: Note

References (0)